Jacob Mauldin

Data Analyst · NYC

Publications

Peer-reviewed research.

A clear separation between papers where I am named directly as a co-author and broader study-group contributions.

Author line

Direct co-authored papers

Papers where I am listed directly in the author line.

Vaccine, 2026

Humoral SARS-CoV-2 vaccine responses are durable in solid organ transplant recipients with and without HIV

Journal of Clinical Investigation, 2023

Site of vulnerability on SARS-CoV-2 spike induces broadly protective antibody against antigenically distinct Omicron subvariants

Contribution

Study-group contributions

Work where I contributed meaningfully — data support, analysis, or publication preparation — without direct author billing.

Immunity, 2024

SARS-CoV-2-infection- and vaccine-induced antibody responses are long lasting with an initial waning phase followed by a stabilization phase

Cell Reports Medicine, 2024

SARS-CoV-2 BA.1 and BA.2 breakthrough infections boost antibody responses to early Omicron subvariants but not BQ.1.1 or XBB.1.5

Nature Communications, 2023

SARS-CoV-2 variant evolution and onward transmission documented through sequential intrahost sampling

mBio, 2024

Cross-reactive antibody response analysis in the Mount Sinai research environment